|
Volumn 177, Issue 5, 2002, Pages 267-273
|
10: Herpes simplex and varicella-zoster virus infections
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIBODY;
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
CHICKENPOX VACCINE;
CORTICOSTEROID;
FAMCICLOVIR;
FOSCARNET;
GANCICLOVIR;
HERPES ZOSTER IMMUNOGLOBULIN;
NUCLEIC ACID;
NUCLEOSIDE ANALOG;
VALACICLOVIR;
VIDARABINE;
VIRUS ANTIGEN;
CHICKENPOX;
CLINICAL FEATURE;
DIAGNOSTIC TEST;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
EXPOSURE;
GENITAL HERPES;
GENITAL TRACT INFECTION;
HERPES LABIALIS;
HERPES SIMPLEX;
HERPES SIMPLEX KERATITIS;
HERPES SIMPLEX VIRUS 1;
HERPES SIMPLEX VIRUS 2;
HERPES ZOSTER;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
IMMUNIZATION;
NEUROLOGIC DISEASE;
NEWBORN INFECTION;
NONHUMAN;
PAIN;
PATHOGENESIS;
PATIENT COUNSELING;
PATIENT EDUCATION;
POSTHERPETIC NEURALGIA;
PREGNANCY;
RECURRENT VIRUS INFECTION;
REVIEW;
SEROLOGY;
VARICELLA ZOSTER VIRUS;
VIRUS IDENTIFICATION;
|
EID: 0037009458
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2002.tb04764.x Document Type: Review |
Times cited : (32)
|
References (33)
|